Peter Brooks, MD

Appointed
2020

Education & Fellowships

Fellowship - Mount Sinai Hospital
Orthopaedic Surgery - Adult Lower Extremity Reconstruction Clinical Fellowship
Toronto, ON Canada
1986

Residency - Brigham & Women's Hospital
Orthopaedic Surgery
Boston, MA USA
1984

Residency - Ottawa Civic Hospital
Ottawa, Ontario CANADA,
1981

Internship - Mt. Sinai Hospital
Toronto, Ontario CANADA,
1980

Medical Education - University of Toronto Faculty of Medicine
Toronto,
1979

Undergraduate - University of Toronto
Chemistry
Toronto, ON Canada
1975

Certifications

• Orthopaedic Surgery

Specialty Interests

Hip and knee replacement and revision surgery, hip resurfacing

Awards & Honors

• Alpha Omega Alpha Honor Medical Society
• Fellow, American Orthopaedic Association
• America's Best Doctors
• Cleveland Top Doctors
• Medical Research Council of Canada fellow, 1985-1987

Innovations & Patents

• First development of metal augments for bone defects on total knee replacement now in use throughout the world for primary and revision knee replacement
• Largest regional experience in hip resurfacing (more conservative than total hip replacement and designed for young, active patients)
• Design team for Synergy Hip (Smith and Nephew)
• Design team for Triathlon Total Knee and Triathlon Revision Knee (Stryker)
• U.S. Patent 5,035,717 for total hip stem
• U.S. Patent 9,271,848 for prosthetic joint planning template

See publications for Peter Brooks, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/10/2023, Dr. Brooks has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Brooks receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Smith & Nephew plc

Royalty Payments. Dr. Brooks receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Smith & Nephew plc

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.